✦ LIBER ✦

Radiotherapy in the management of endometrial carcinoma with cervical involvement

✍ Scribed by Kathryn Greven; Warren Olds

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 309 KB
Volume: 60
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19871015)60:8<1737::aid-cncr2820600810>3.0.co;2-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nature of cervical involvement in endome

Nature of cervical involvement in endometrial carcinoma

✍ Dale M. Larson; Larry J. Copeland; H. Steven Gallager; David M. Gershenson; Ralp 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 1 views

Forty years' evolution in the management

Forty years' evolution in the management of patients with endometrial carcinoma

✍ Orliss Wildermuth 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

Involvement of mutations in the DPC4 pro

Involvement of mutations in the DPC4 promoter in endometrial carcinoma development

✍ Yong Zhou; Hidenori Kato; Dan Shan; Rieko Minami; Sohei Kitazawa; Takao Matsuda; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 1 views

To define the target of chromosome 18q loss of heterozygosity, which is prevalent in endometrial carcinomas, we made a deletion map from 64 tumors. Loss of heterozygosity on 18q was found in 20 tumors. Among these, 14 tumors carried deletions at the 18q21.1 region, where the DPC4 gene is located. DP

Studies of chemical sensitization in the

Studies of chemical sensitization in the radiotherapy of oral and cervical carcinomas

✍ S. Krishnamurthi; V. Shanta; M. Krishnan Nair 📂 Article 📅 1967 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB 👁 1 views

The primary treatment for carcinomas of the oral cavity and the uterine cervix at the Cancer Institute in Madras, India is radiotherapy followed by radical surgery if and to the extent necessary. Following radiation alone, the five-year disease-free survival rate of patients with oral cancer is only

External irradiation in the management o

External irradiation in the management of stage II endometrial carcinoma. A logical approach

✍ James D. Gagnon; William T. Moss; Linda S. Gabourel; Kenneth R. Stevens Jr 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 2 views

Reduction of syndecan-1 mRNA in cervical

Reduction of syndecan-1 mRNA in cervical-carcinoma cells is involved with the 3′ untranslated region

✍ Kazuyoshi Nakanishi; Naohisa Yoshioka; Kiyomasa Oka; Akira Hakura 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 147 KB 👁 1 views

Syndecan-1 is a transmembrane proteoglycan expressed predominantly in epithelial cells. Studies with immunohistochemistry have shown that syndecan-1 expression is reduced in carcinoma derived from human epidermis. Here we show that syndecan-1 mRNA, which is abundant in human primary keratinocyte (HK